Passive immune therapy against malignant melanoma

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/30 (2006.01)

Patent

CA 2530655

Disclosed is the use of antibodies for producing an immunizing vaccine against HMW-MAA on melanomas.

Utilisation d'anticorps pour la fabrication d'un vaccin destiné à l'immunisation contre l'antigène HMW-MAA sur des mélanomes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Passive immune therapy against malignant melanoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Passive immune therapy against malignant melanoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Passive immune therapy against malignant melanoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1371738

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.